PP
GOSS icon

PDT Partners’s Gossamer Bio GOSS Stock Holding History

PDT Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-212
Closed -$204K – 737
2022
Q3 		$204K Sell
212
-660
-76% -$655K 0.03% 713
2022
Q2 		$584K Sell
872
-387
-31% -$240K 0.05% 560
2022
Q1 		$875K Buy
1,259
+169
+16% +$130K 0.08% 415
2021
Q4 		$986K Buy
1,090
+217
+25% +$206K 0.08% 360
2021
Q3 		$878K Sell
873
-348
-29% -$256K 0.06% 367
2021
Q2 		$793K Sell
1,221
-189
-13% -$131K 0.05% 413
2021
Q1 		$1.04M Sell
1,410
-52
-4% -$41.9K 0.08% 367
2020
Q4 		$1.13M Buy
1,462
+1,272
+669% +$1M 0.08% 305
2020
Q3 		$189K Sell
190
-33
-15% -$35K 0.01% 636
2020
Q2 		$232K Buy
+223
New +$224K 0.02% 573

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PDT Partners's GOSS Position: Q4 2022 in Review

PDT Partners sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 212 shares — an estimated $204K sold.

PDT Partners first reported a position in GOSS in Q2 2020 and held it in 10 quarters. The position peaked at $1.13M in Q4 2020. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • PDT Partners reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 212 Gossamer Bio shares in Q4 2022, an estimated $204K.
  • PDT Partners first reported a position in Gossamer Bio in Q2 2020 and held it in 10 quarters.
  • PDT Partners's Gossamer Bio position peaked at $1.13M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.